Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9153 - 9160 of 11616 results
UPDATE: FTC Plans Review of YouTube Kids App
April 10, 2015| Blog| Viewpoint
Bloomberg Product Safety Article Misses the Mark; U.S. Product Safety Economy Safer Than Ever
April 9, 2015| Blog| Viewpoint
California Drought Calls for Bold Energy Solutions
April 9, 2015| Blog| Viewpoint
Spring Spotlight on Food Labeling, Safety & Nutrition
April 9, 2015| Blog| Viewpoint
CMS Takes Initial Steps to Address Medicare & Medicaid Coverage for Biosimilars
April 9, 2015| Blog| Viewpoint
ECO:nomics 2015 - Top 10 Takeaways
April 8, 2015| Blog| Viewpoint
Massachusetts Announces Significant Changes to the Medical Marijuana Dispensary Program
April 8, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.